US team gets green-light for lymphatic agent trial
This article was originally published in Clinica
Executive Summary
The US FDA has given researchers at the University of California, San Diego Cancer Center, the go-ahead to begin a clinical trial of a radiolabelled agent that could help doctors diagnose breast cancer patients more accurately.